Status:
COMPLETED
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
Ministry of Science and Technology, Taiwan
Conditions:
Schizophrenia
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
This study is a 12-week randomized-controlled clinical trial. It will be planned to conduct in a total of 120 male and female subjects from the Department of Psychiatry at Kaohsiung Chang Gung Memoria...
Detailed Description
This 12-week randomized-controlled clinical trial will be planned to conduct in a total of 120 male and female subjects from the Department of Psychiatry at Kaohsiung Chang Gung Memorial Hospital. Eli...
Eligibility Criteria
Inclusion
- The patient has been diagnosed of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition criteria (DSM-5) criteria
- The patient has the ability to complete the written informed consent
Exclusion
- The patient has been diagnosed with organic mental disorders, intelligence disability, dementia, major depressive disorder, bipolar affective disorder, and alcohol or substance use disorder
- The patient has major systemic physical diseases, including cardiovascular diseases, uncontrollable arrhythmia, renal diseases, liver diseases or thyroid diseases
- The patient has certified as physical disability
- The patient is pregnant or has genetic diseases or infectious conditions
Key Trial Info
Start Date :
September 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2019
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04411979
Start Date
September 27 2018
End Date
October 15 2019
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan